Abstract:Both cardiovascular disease and cancer continue to be causes of morbidity and mortality all over the world. Preventing and treating heart disease in patients undergoing cancer treatment remain an important and ongoing challenge for improving the lives of cancer patients, but also for their survival. Despite ongoing efforts to improve patient survival, minimal advances have been made in the early detection of cardiovascular disease in patients suffering from cancer. Understanding the communication between cance… Show more
“…Hence, the relationship of the two diseases indicates a crosstalk between the two illnesses. The perception of this crosstalk has crucial implications for collaborating oncology with cardiology to prevent and treat these two related diseases (11). However, the association between cancer and cardiovascular disease is not novel.…”
Section: A Short Look At the Cardio-oncologymentioning
Reverse cardio-oncology addressed the risk of ensuing cancer in individuals with heart disease. It is imperative to collaborate oncology with cardiology to effectively prevent and treat related diseases.
“…Hence, the relationship of the two diseases indicates a crosstalk between the two illnesses. The perception of this crosstalk has crucial implications for collaborating oncology with cardiology to prevent and treat these two related diseases (11). However, the association between cancer and cardiovascular disease is not novel.…”
Section: A Short Look At the Cardio-oncologymentioning
Reverse cardio-oncology addressed the risk of ensuing cancer in individuals with heart disease. It is imperative to collaborate oncology with cardiology to effectively prevent and treat related diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.